Symbolbild · KI-generiert
K-Bro Linen Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
K-Bro Linen Inc is a healthcare and hospitality laundry and linen processor in Canada. It operates in major cities across Canada, and has two distribution centers, providing management services and laundry processing of hospitality, healthcare, and specialty linens. The company provides vital products and services that help people heal, travel, live, and play. It helps hospitals and extended care centers care for the young, old, and vulnerable in environmentally responsible ways. It operates through two divisions, which are the Canadian division and the United Kingdom division.
Company description as published by the issuer via TMX Money.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| K-Bro Linen Inc. | KBL | TSX | 439 Mio. USD |
| Neuropace, Inc. | NPCE | NASDAQ | 439 Mio. USD |
| Sagimet Biosciences Inc. Series A | SGMT | NASDAQ | 439 Mio. USD |
| Cabaletta Bio, Inc. | CABA | NASDAQ | 437 Mio. USD |
| Kyverna Therapeutics, Inc. | KYTX | NASDAQ | 444 Mio. USD |
| Pacific Biosciences of California, Inc. | PACB | NASDAQ | 435 Mio. USD |
| Tilray Brands Inc. | TLRY | TSX | 434 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.